CASP3 and small cell lung carcinoma: The combination of ABT-737 and chloroquine resulted in higher levels of caspase-3 activation relative to either treatment alone in several SCLC lines (Figure 2A), and in the cell lines derived from primary patient xenografts (Figure 2B).